OPKO Health, Inc.

NasdaqGS:OPK Stok Raporu

Piyasa değeri: US$1.0b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

OPKO Health Yönetim

Yönetim kriter kontrolleri 3/4

OPKO Health's CEO'su Phil Frost, Mar2007 tarihinde atandı, in görev süresi 17.58 yıldır. in toplam yıllık tazminatı $ 2.28M olup, şirket hissesi ve opsiyonları dahil olmak üzere 42.2% maaş ve 57.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 35.32% ine doğrudan sahiptir ve bu hisseler $ 364.20M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 9.6 yıl ve 15.5 yıldır.

Anahtar bilgiler

Phil Frost

İcra Kurulu Başkanı

US$2.3m

Toplam tazminat

CEO maaş yüzdesi42.2%
CEO görev süresi17.6yrs
CEO sahipliği35.3%
Yönetim ortalama görev süresi9.6yrs
Yönetim Kurulu ortalama görev süresi15.5yrs

Son yönetim güncellemeleri

Recent updates

Not Enough To Keep OPKO Health Flying

Aug 28

OPKO Health, Inc. (NASDAQ:OPK) Not Flying Under The Radar

Dec 30
OPKO Health, Inc. (NASDAQ:OPK) Not Flying Under The Radar

Is OPKO Health (NASDAQ:OPK) A Risky Investment?

Oct 03
Is OPKO Health (NASDAQ:OPK) A Risky Investment?

OPKO Health, Inc.'s (NASDAQ:OPK) 28% Share Price Surge Not Quite Adding Up

Jul 24
OPKO Health, Inc.'s (NASDAQ:OPK) 28% Share Price Surge Not Quite Adding Up

Would OPKO Health (NASDAQ:OPK) Be Better Off With Less Debt?

Jun 07
Would OPKO Health (NASDAQ:OPK) Be Better Off With Less Debt?

Is OPKO Health (NASDAQ:OPK) Using Too Much Debt?

Jan 04
Is OPKO Health (NASDAQ:OPK) Using Too Much Debt?

OPKO Health: Assessing If Significant Potential Can Be Realized

Sep 15

OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

Sep 05
OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

OPKO Health: 14%+ Short Interest Means More Volatility Over The Near Term

Jun 21

OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

Apr 29
OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

OPKO Health: A Great Long-Term Investment In Health

Apr 05

OPKO Health Is Risky But Might Make You Money

Mar 29

Analysts Have Just Cut Their OPKO Health, Inc. (NASDAQ:OPK) Revenue Estimates By 14%

Feb 27
Analysts Have Just Cut Their OPKO Health, Inc. (NASDAQ:OPK) Revenue Estimates By 14%

CEO Tazminat Analizi

Phil Frost'un ücretlendirmesi OPKO Health'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$243m

Mar 31 2024n/an/a

-US$252m

Dec 31 2023US$2mUS$960k

-US$189m

Sep 30 2023n/an/a

-US$208m

Jun 30 2023n/an/a

-US$209m

Mar 31 2023n/an/a

-US$291m

Dec 31 2022US$972kUS$960k

-US$328m

Sep 30 2022n/an/a

-US$317m

Jun 30 2022n/an/a

-US$202m

Mar 31 2022n/an/a

-US$117m

Dec 31 2021US$2mUS$960k

-US$30m

Sep 30 2021n/an/a

US$76m

Jun 30 2021n/an/a

US$71m

Mar 31 2021n/an/a

US$121m

Dec 31 2020US$2mUS$960k

US$31m

Sep 30 2020n/an/a

-US$114m

Jun 30 2020n/an/a

-US$200m

Mar 31 2020n/an/a

-US$293m

Dec 31 2019US$1mUS$960k

-US$315m

Sep 30 2019n/an/a

-US$279m

Jun 30 2019n/an/a

-US$244m

Mar 31 2019n/an/a

-US$191m

Dec 31 2018US$2mUS$960k

-US$153m

Sep 30 2018n/an/a

-US$295m

Jun 30 2018n/an/a

-US$303m

Mar 31 2018n/an/a

-US$314m

Dec 31 2017US$971kUS$960k

-US$305m

Tazminat ve Piyasa: Phil 'ın toplam tazminatı ($USD 2.28M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 3.23M ).

Tazminat ve Kazançlar: Phil şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Phil Frost (88 yo)

17.6yrs

Görev süresi

US$2,277,200

Tazminat

Dr. Phillip Frost, also known as Phil, M.D., Ph D., is Director of Non-Invasive Monitoring Systems, Inc. since June 01, 2023. He has been the Chairman, Chief Executive Officer and Director of OPKO Health,...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Phillip Frost
Chairman & CEO17.6yrsUS$2.28m35.32%
$ 364.2m
Jane Hsiao
Vice Chairman & Chief Technical Officer17.7yrsUS$2.19m4.79%
$ 49.4m
Elias Zerhouni
President & Vice Chairman2.4yrsUS$2.19m2.95%
$ 30.4m
Adam Logal
Senior VP17.6yrsUS$1.81m0.026%
$ 266.9k
Steven Rubin
Executive VP of Administration & Director17.4yrsUS$1.94m0.89%
$ 9.2m
Akhtar Ashfaq
Senior Vice President of Clinical Research & Development and Medical Affairs - Opko Renal7.6yrsVeri yokVeri yok
Gary Nabel
Chief Innovation Officer & Director2.4yrsVeri yok5.83%
$ 60.1m
Charles Bishop
Chief Executive Officer of OPKO Renal11.6yrsVeri yokVeri yok
Antonio Cruz
President of Transition Therapeuticsno dataVeri yokVeri yok
Hans Berner
President of OPKO Health Iberoamericano dataVeri yokVeri yok
Damien Burke
Chief Executive Officer of EirGen Pharma4.9yrsVeri yokVeri yok
Craig Allen
Interim CEO2.2yrsVeri yokVeri yok

9.6yrs

Ortalama Görev Süresi

71.5yo

Ortalama Yaş

Deneyimli Yönetim: OPK 'un yönetim ekibi deneyimli ve deneyimlidir ( 9.6 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Phillip Frost
Chairman & CEO17.6yrsUS$2.28m35.32%
$ 364.2m
Jane Hsiao
Vice Chairman & Chief Technical Officer17.7yrsUS$2.19m4.79%
$ 49.4m
Elias Zerhouni
President & Vice Chairman2.4yrsUS$2.19m2.95%
$ 30.4m
Steven Rubin
Executive VP of Administration & Director17.7yrsUS$1.94m0.89%
$ 9.2m
Gary Nabel
Chief Innovation Officer & Director2.4yrsVeri yok5.83%
$ 60.1m
Roger Medel
Independent Director3.8yrsUS$69.90k0%
$ 0
Richard Pfenniger
Lead Independent Director16.8yrsUS$134.80k0.047%
$ 484.3k
Richard Krasno
Independent Director7.7yrsUS$92.40k0.015%
$ 153.9k
John Paganelli
Independent Director20.8yrsUS$84.90k0.057%
$ 586.4k
Prem Lachman
Independent Director3.6yrsUS$92.40k0%
$ 0
Lin-Tsing Yu
Independent Director15.5yrsUS$62.40k0.0096%
$ 99.1k

15.5yrs

Ortalama Görev Süresi

77yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: OPK 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 15.5 yıldır).